Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Germany Focuses on Private Sector Treatment Access Demand for obesity GLP-1 treatment in Germany is projected to grow at a CAGR of 19.6%, constrained by statutory health insurance exclusions for anti-obesity medications that limit public reimbursement
Simon Medicaid GLP-1 Coverage and Prescribing Patterns Studying how state Medicaid coverage of GLP-1s for weight management affects prescribing and spending, using staggered adoption across states, from Coady Wing, Wei-Lun Lo, Maddie Potter, Tarik Yuce, Alberto Ortega, John Cawley, Thuy D
Recently, Eli Lilly reported they anticipate submitting Orforglipron for FDA approval in the second half of 2025, with potential availability shortly after if approved
In whole-cell voltage clamp experiments, excitatory postsynaptic currents (EPSCs) were measured at the membrane potential of 70 mV for 3 min
Furthermore, the precise mechanisms of glutathiones impact remain unclear, and future research should investigate its specific roles in chemotherapy resistance and cell survival
